The development, application and limitations of breast cancer cell lines to study tamoxifen and aromatase inhibitor resistance
about
Genetically engineered ERα-positive breast cancer mouse models.VN/14-1 induces ER stress and autophagy in HP-LTLC human breast cancer cells and has excellent oral pharmacokinetic profile in female Sprague Dawley ratsChallenging the roles of CD44 and lipolysis stimulated lipoprotein receptor in conveying Clostridium perfringens iota toxin cytotoxicity in breast cancer.Method for obtaining primary ovarian cancer cells from solid specimensDrug Efflux Transporters Are Overexpressed in Short-Term Tamoxifen-Induced MCF7 Breast Cancer Cells.SERPINA1 is a direct estrogen receptor target gene and a predictor of survival in breast cancer patients.Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells.Modelling the Tox21 10 K chemical profiles for in vivo toxicity prediction and mechanism characterization.Antiestrogen Resistance and the Application of Systems BiologyInhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat).Deregulation of IGF-binding proteins -2 and -5 contributes to the development of endocrine resistant breast cancer in vitro.Novel aromatase inhibitors selection using induced fit docking and extra precision methods: Potential clinical use in ER-alpha-positive breast cancer.ERα-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancer.
P2860
Q33578641-1BAD783A-5F1B-4061-8192-A4C10E293AB4Q33717781-81C7C1B1-0EF8-443B-B5B6-D35683E33555Q33864348-454067AC-BFC3-4203-B913-D704A82E8181Q33978862-510D1B44-9810-46D9-9817-857A6DFBE5DDQ35958984-A10C6A33-00A9-42F4-90C8-E00C85BBBCEFQ36413297-D8038735-2D55-42C0-89EF-437A1318827BQ36578211-327B651E-07E9-4F16-B3D9-53C5FAF881CAQ36648761-19F7EE67-570A-4521-B2C1-A4017CD4DCE7Q36713946-3C9AB646-0BE1-42BE-8F04-C3437FD081DBQ36799721-432D5EAB-202B-448F-ABD5-E9F90E261DD9Q37362627-C444A265-3F34-4A39-B836-57ECD9A3B057Q37658821-00C972F7-7DF2-40AD-B731-0F7C2729D8F3Q55426345-68A5DA29-7C33-49F9-A4F2-5DB74A12ECE9
P2860
The development, application and limitations of breast cancer cell lines to study tamoxifen and aromatase inhibitor resistance
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The development, application a ...... aromatase inhibitor resistance
@ast
The development, application a ...... aromatase inhibitor resistance
@en
type
label
The development, application a ...... aromatase inhibitor resistance
@ast
The development, application a ...... aromatase inhibitor resistance
@en
prefLabel
The development, application a ...... aromatase inhibitor resistance
@ast
The development, application a ...... aromatase inhibitor resistance
@en
P2860
P1476
The development, application a ...... aromatase inhibitor resistance
@en
P2093
Cynthie Wong
Shiuan Chen
P2860
P356
10.1016/J.JSBMB.2011.12.005
P577
2012-01-08T00:00:00Z